| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
66,158 |
58,346 |
$3.83M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
25,501 |
23,036 |
$2.16M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
18,727 |
16,352 |
$1.44M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
16,563 |
15,392 |
$1.34M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
35,881 |
32,410 |
$1.15M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
8,413 |
7,619 |
$833K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,773 |
5,472 |
$478K |
| D0145 |
Oral evaluation for a patient under three years of age |
10,346 |
9,577 |
$319K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,093 |
2,797 |
$267K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
6,984 |
6,192 |
$179K |
| 87631 |
|
1,747 |
1,481 |
$166K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,414 |
3,969 |
$158K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
2,116 |
1,862 |
$118K |
| 99460 |
|
1,246 |
1,121 |
$94K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,493 |
1,253 |
$93K |
| 92551 |
|
11,392 |
10,294 |
$92K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,947 |
5,590 |
$77K |
| 99051 |
|
2,451 |
2,311 |
$37K |
| 87276 |
|
2,297 |
2,170 |
$30K |
| 90671 |
|
3,159 |
2,532 |
$29K |
| 83655 |
|
2,791 |
2,604 |
$28K |
| 87275 |
|
2,300 |
2,172 |
$28K |
| 99462 |
|
774 |
555 |
$27K |
| 96161 |
|
5,426 |
4,844 |
$22K |
| T1023 |
Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter |
1,210 |
1,075 |
$19K |
| D1206 |
Topical application of fluoride varnish |
920 |
846 |
$19K |
| 99173 |
|
7,089 |
6,380 |
$17K |
| 95117 |
|
1,528 |
1,101 |
$13K |
| 80061 |
Lipid panel |
1,037 |
919 |
$11K |
| 90670 |
|
10,327 |
9,707 |
$10K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
131 |
110 |
$10K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,155 |
1,066 |
$10K |
| 96127 |
|
2,835 |
2,541 |
$9K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
946 |
862 |
$6K |
| 87807 |
|
452 |
433 |
$5K |
| 85018 |
|
3,915 |
3,573 |
$4K |
| 99050 |
|
299 |
270 |
$4K |
| 0071A |
|
115 |
96 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
210 |
179 |
$3K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
3,728 |
3,399 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
121 |
117 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
330 |
246 |
$2K |
| 0072A |
|
64 |
60 |
$2K |
| 90716 |
|
256 |
211 |
$2K |
| 90461 |
|
6,727 |
5,892 |
$2K |
| 96380 |
|
104 |
104 |
$2K |
| 81001 |
|
406 |
371 |
$1K |
| 90686 |
|
6,737 |
6,192 |
$1K |
| 90651 |
|
1,132 |
1,040 |
$922.07 |
| 99464 |
|
13 |
13 |
$883.23 |
| 90715 |
|
606 |
533 |
$597.23 |
| 90648 |
|
9,170 |
8,198 |
$554.22 |
| 90473 |
|
71 |
58 |
$320.58 |
| 96160 |
|
303 |
230 |
$311.77 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
58 |
37 |
$239.94 |
| 96381 |
|
33 |
14 |
$77.65 |
| 90707 |
|
243 |
199 |
$71.34 |
| 90633 |
|
4,888 |
4,509 |
$63.02 |
| 90647 |
|
2,760 |
2,631 |
$53.33 |
| 90661 |
|
196 |
195 |
$22.62 |
| 90734 |
|
834 |
738 |
$14.19 |
| 90710 |
|
627 |
518 |
$7.00 |
| 90685 |
|
157 |
157 |
$6.06 |
| 90723 |
|
9,527 |
8,626 |
$5.01 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
242 |
187 |
$4.07 |
| 94760 |
|
12 |
12 |
$3.68 |
| 90700 |
|
270 |
247 |
$3.00 |
| 90696 |
|
528 |
434 |
$2.82 |
| 97803 |
|
8,228 |
7,800 |
$1.14 |
| 36416 |
|
3,398 |
2,891 |
$1.00 |
| 90660 |
|
73 |
73 |
$0.60 |
| 90674 |
|
561 |
531 |
$0.25 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
234 |
179 |
$0.07 |
| 3725F |
|
2,024 |
1,695 |
$0.00 |
| 99401 |
|
17 |
12 |
$0.00 |
| 90680 |
|
8,346 |
7,543 |
$0.00 |
| 91307 |
|
137 |
128 |
$0.00 |
| 3008F |
|
8,883 |
7,985 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
794 |
608 |
$0.00 |
| 3352F |
|
111 |
80 |
$0.00 |
| 90381 |
|
67 |
67 |
$0.00 |
| 3353F |
|
61 |
52 |
$0.00 |
| 3351F |
|
15 |
12 |
$0.00 |
| G0010 |
Administration of hepatitis b vaccine |
414 |
347 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
30 |
28 |
$0.00 |